Abstract
There is robust epidemiological evidence that susceptibility to tuberculosis is in part heritable. This has driven the use of genetics to try to find the genes and pathways involved that could in the longer term contribute towards the development of new therapies and a better vaccine for this major global health problem. This paper reviews the progress made in the field to date, and discusses the challenges inherent in undertaking genetics studies on a complex disease with clinically diverse phenotypes, that affects many genetically different populations and which is further complicated by the presence of a pathogen which has a genome too.
Keywords: Genetic linkage, genome wide association studies, immune response genes, Mendelian susceptibility to mycobacterial disease, single nucleotide polymorphisms, tuberculosis.
Current Respiratory Medicine Reviews
Title:The Contribution of Host Genetics to TB Disease
Volume: 9 Issue: 3
Author(s): Melanie J. Newport
Affiliation:
Keywords: Genetic linkage, genome wide association studies, immune response genes, Mendelian susceptibility to mycobacterial disease, single nucleotide polymorphisms, tuberculosis.
Abstract: There is robust epidemiological evidence that susceptibility to tuberculosis is in part heritable. This has driven the use of genetics to try to find the genes and pathways involved that could in the longer term contribute towards the development of new therapies and a better vaccine for this major global health problem. This paper reviews the progress made in the field to date, and discusses the challenges inherent in undertaking genetics studies on a complex disease with clinically diverse phenotypes, that affects many genetically different populations and which is further complicated by the presence of a pathogen which has a genome too.
Export Options
About this article
Cite this article as:
Newport J. Melanie, The Contribution of Host Genetics to TB Disease, Current Respiratory Medicine Reviews 2013; 9 (3) . https://dx.doi.org/10.2174/1573398X113099990022
DOI https://dx.doi.org/10.2174/1573398X113099990022 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Advance Synthetic Approaches to 1,2,3-triazole Derived Compounds: State of the Art 2004-2020
Current Organocatalysis Modern Drug Discovery Technologies: Opportunities and Challenges in Lead Discovery
Combinatorial Chemistry & High Throughput Screening Tuberculosis Drug Targets
Current Drug Targets One-Pot Synthesis of 5-Unsubstituted-6-Aroyl[1,2,4]triazolo[1,5-a]pyrimidine Utilizing Biginelli-Like Multicomponent Reaction of Enaminones with 3-Amino-1,2,4- triazole as the Urea Component
Current Organic Synthesis Laboratory Techniques for Human Viral Encephalitis Diagnosis
Infectious Disorders - Drug Targets Non-Antidepressant Treatment of Social Anxiety Disorder: A Review
Current Clinical Pharmacology Formulation of Ofloxacin Loaded Lipospheres with Improved Oral Bioavailability
Pharmaceutical Nanotechnology Short Antimicrobial Peptides
Recent Patents on Anti-Infective Drug Discovery On the Diversity of Oxidative Bioactivation Reactions on Nitrogen- Containing Xenobiotics
Current Drug Metabolism 1,2,5-Thiadiazole Scaffold: A Review on Recent Progress in Biological Activities
Combinatorial Chemistry & High Throughput Screening Novel Adjunctive Therapies for the Treatment of Tuberculosis
Current Molecular Medicine Current Study of Natural Products for Medicinal Chemistry
Current Medicinal Chemistry Adenylating Enzymes in Mycobacterium tuberculosis as Drug Targets
Current Topics in Medicinal Chemistry Cutaneous Adverse Drug Reactions Caused by Antituberculosis Drugs
Inflammation & Allergy - Drug Targets (Discontinued) Withdrawal Notice: Drug Repurposing for Prospective Anti-Cancer Agents Along with the Clinical Status of the Repurposed Drug
Anti-Cancer Agents in Medicinal Chemistry Biologic Therapy in Inflammatory Eye Conditions (Ophtalmology): Safety Profile
Current Drug Safety MmpL3 Inhibitors: Diverse Chemical Scaffolds Inhibit the Same Target
Mini-Reviews in Medicinal Chemistry Subject Index To Volume 7
Current Drug Targets Monoclonal Antibodies in Allergy; Updated Applications and Promising Trials
Recent Patents on Inflammation & Allergy Drug Discovery Correlation Between Clinical Manifestation and Radiological Findings In Pulmonary Tuberculosis-Human Immunodeficiency Virus Coinfection Patients In Sanglah Hospital, Bali, Indonesia
Current HIV Research